|
|
Volumn 2, Issue 10, 2003, Pages 765-766
|
|
FDA alerts asthmatics to drug safety risk
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETA 2 ADRENERGIC RECEPTOR;
BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
BUDESONIDE PLUS FORMOTEROL;
CORTICOSTEROID;
FLUTICASONE PROPIONATE PLUS SALMETEROL;
SALMETEROL XINAFOATE;
ASTHMA;
DEATH;
DRUG APPROVAL;
DRUG FATALITY;
DRUG RESEARCH;
DRUG SAFETY;
DRUG SURVEILLANCE PROGRAM;
FOOD AND DRUG ADMINISTRATION;
GENETIC DIFFERENCE;
GENETIC POLYMORPHISM;
HUMAN;
NOTE;
PRIORITY JOURNAL;
RISK ASSESSMENT;
RISK BENEFIT ANALYSIS;
UNITED STATES;
|
|
EID: 0242331764
PISSN: 14741776
EISSN: None
Source Type: Journal
DOI: 10.1038/nrd1222 Document Type: Note |
|
Times cited : (5)
|
|
References (0)
|